View Article

Abstract

The many bioactive chemicals and good effects of plants have made them a major source of treatment agents for many generations. The medicinal plant Dracaena reflexa Lam. which is part of the family Asparagaceae has attracted attention because of its pharmacological properties and traditional uses. The plants biological actions lead to important plant chemicals such as flavonoids, alkaloids, tannins, saponins, steroids and phenolic compounds. The aim of this study is to present the plants features, plant chemicals, traditional uses and medical value of Dracaena reflexa. Pharmacological effects, like anti-inflammatory, anti-nociceptive, antioxidant, antibacterial, anticonvulsant, anxiolytic, wound healing, Thrombolytic, cholinesterase inhibitory and tyrosinase inhibitory have been reported in many scientific studies. Studies have shown that ethanolic leaf extract of dracaena reflexa shows the good anti-inflammatory and analgesics activity whereas other antibacterial activity due to presence of phenolic compound and flavonoids. The pharmacological activities of dracaena reflexa may be related to its abundant phytochemical ingredients which contribute to the reduction of oxidative stress inhibition of microbial growth, modulation of inflammatory responses and protective effects against various pathological conditions. The plant also showed potential neuroprotective effects through cholinesterase inhibitions and possible applications in skin related disorders through wound healing and tyrosinase inhibitory activities. To summarise dracaena reflexa might be a potential medicinal plant with high therapeutics potential and can be considered as a potential source for the development of future herbal medicines. However, more studies involving isolations and characterisations of active compounds, detailed pharmacological investigations and clinical evaluations are needed to established its safety and efficacy for therapeutic applications.

Keywords

Dracaena reflexa, medicinal plant, phytochemicals, pharmacological activities, therapeutic potential.

Introduction

× Popup Image

The medicinal plant is really important for keeping people healthy. It has been this way since a time ago. People still use plants a lot for health care all around the world. The World Health Organization says that people use thousands of plant species. This is because they are safe and they work well. Many people also like them because of their culture. Another good thing, about plants is that they have fewer bad side effects compared to some manmade medicines. Medicinal plants are still a part of health care today. Plants have a lot of healing power. This is because they have things in them like alkaloids, flavonoids and tannins. Plants also have compounds, terpenoids, saponins, steroids and glycosides. These things in plants can do a lot of good for our health. Plants are very important when it comes to finding medicines. We can make drugs from the things that plants naturally produce. The good things in plants, like alkaloids, flavonoids and tannins have good effects on our bodies. Plants and the things they produce, like compounds, terpenoids, saponins, steroids and glycosides can help us make new medicines that can make people feel better. Medicinal herbs are really valuable because they have compounds in different parts of the plant. These compounds can help prevent and manage illnesses. Medicinal herbs are great for our health. We can find compounds in the leaves, roots and flowers of medicinal herbs. This is why medicinal herbs are so useful, in managing and preventing illnesses like medicinal herbs can do.1

Dracaena reflexa Lam. (Family Asparagaceae) is a medicinal plant that is rich in phytochemicals and has traditional therapeutic applications. The plant is rich in several bio active constituents like flavonoids, saponins, alkaloids, tannins, steroids and phenolic compounds which are responsible for its reported pharmacological activities. Traditional uses and scientific investigations suggest potential biological activities of D. reflexa making it a promising candidate for further pharmacological research. Thus, the present review deals with the botanical characteristics, phytochemistry, traditional applications, and therapeutic potential of Dracaena reflexa Lam.1 The bio-fibers extracted from Dracaena reflexa was considered as a potential reinforcement for polymer composite. These fibers have selected for numerous reasons: It is commonly grown in all the climate conditions. Its leaves are consumed as medicine for malarial fever, poisoning, dysentery, and diarrhea and dysmenorrhea. So, it is cultivated for commercial use. Dracaena reflexa was used to clean and remove considerable amount of toxins from the air which was proved by the NASA (National Aeronautics and Space Administration).2

Kingdom: Plantae

Subkingdom: Tracheobionta

Super division: Spermatophyte

Division: Magnoliophyta

Class: Liliopsida

Subclass: Monocots

Order: Asparagales

Family: Asparagaceae

Subfamily: Nolinoideae

Genus: Dracaena

Species: D. reflexa3

  

Fig 01: Dracaena reflexa plant and leaves

2. PHARMACOLOGICAL ACTIVITY:

Sr.

No.

Activity

Experimental

Model

Method of Extract

Methodology

Results

Reference

1

Anti-convulsant

activity

Strychnine induced seizure model in Wistar rats

Aqueous leaf extract

The anticonvulsant activity of aqueous leaf extract of Dracaena reflexa was evaluated in strychnine induced seizure model in Wistar rats. Rats were divided into five groups (n= 5) consisting of a negative control (distilled water, 0.5 mL/kg), positive control (diazepam, 10 mg/kg) and three treatment groups receiving the aqueous extract at 50, 100 and 200 mg/kg orally. One hour after treatment, seizures were induced by intraperitoneal injection of strychnine (2.5 mg/kg). Animals were observed for 10 min and the latency to seizure onset and duration of convulsions were noted. Statistical analysis was performed by one-way ANOVA followed by post hoc Tukey’s and Sidak tests. P < 0.05 was considered statistically significant.

Results suggest that the aqueous extract significantly delayed the onset of seizures at all the tested doses indicating anticonvulsant activity. However, the extract did not significantly reduce the duration of seizure than that of control group. The results support the traditional use of D. reflexa for the management of epilepsy.

Judicael BD et.al., (2022)

2

Anxiolytic activity

Open field test and forced swimming test

 

 

 

 

 

 

Aqueous leaf extract

Anxiolytic activity was evaluated by open field test and forced swimming test. In the open field test, rats were treated with distilled water (control), diazepam (10 mg/kg) or D. reflexa extract (50, 100 and 200 mg/kg). Each animal was placed in an open field arena divided into 25 equal squares within an hour and the number of squares crossed in 5 minutes was recorded as a measure of locomotor activity. In the forced swimming test, clomipramine (25 mg/kg) was used as positive control and swimming time, climbing time and immobility time were recorded for 6 min.

In the open field test, the extract caused a significant reduction in locomotor activity similar to that of diazepam suggesting anxiolytic and sedative effects. D. reflexa treatment increased the immobility time and decreased the swimming and climbing time in a dose-dependent manner in the forced swimming test. The results of the study showed that aqueous leaf extract has anxiolytic activity but the increased immobility may also be an indicator of central nervous system depressant activity.

Judicael BD et.al., (2022)

 

 

 

 

 

 

 

3

Wound healing activity

In vitro scratch assay on human skin fibroblast (HSF) cell

Aqueous methanolic extract

The in vitro scratch assay on Human Skin Fibroblast (HSF) cells was used to assess the wound-healing activity of the aqueous methanolic extract of Dracaena reflexa stem (DRSE). The non-toxic concentrations of the extract were determined using sulforhodamine B (SRB) assay. HSF cells were cultured to form a confluent monolayer and then a scratch wound was made. Cells were treated with DRSE and incubated at appropriate conditions. Cell migration was evaluated under the microscope at 0, 24, 48, and 72 hours and the wound width was measured to determine the reduction in wound closure.

DRSE (10 and 20 μg/mL) significantly enhanced the migration of fibroblast and wound closure rate as compared to untreated control cells. The wound-healing activity of DRSE might be attributed to the presence of the bioactive compounds like flavonoids, phenolic compounds and steroidal saponins which helps in fibroblast migration and tissue repair.

Raslan MA et.al., (2022)

4

Anti- Thrombolytic activity

In vitro clot lysis assay

 

 

 

Methanolic and Chloroform extractions

Abnormal blood clots can lead to cardiovascular complications such as thrombosis, stroke, and myocardial infarction. Thrombolytic medications act by dissolving blood clots that contain fibrin and restoring the flow of blood. The thrombolytic potential of D. reflexa extracts was evaluated by in vitro clot lysis assay which measures the ability of plant extracts to dissolve blood clots. Streptokinase has been the classic thrombolytic agent

The methanolic and chloroform fractions showed significant activity of dissolving clots but the effect was less than that of streptokinase. The activity may be related to the presence of phytoconstituents capable to induce fibrinolytic processes. These results suggest the presence of compounds with potential beneficial cardiovascular effect in D. reflexa and provide a platform for further studies on thrombolytic drug discovery.

Ghallo BA et.al., (2022

5

Cholinesterase inhibitory activity

AChE and BChE enzyme inhibition assays

n-butanol and methanolic extractions

The potential of Dracaena reflexa extracts to inhibit cholinesterase was evaluated using AChE and BChE enzyme inhibition assays and galantamine as standard drug.

The extracts showed inhibitory activity against both enzymes. The n-butanol fraction exhibited the highest inhibition of AChE and the methanolic extract showed significant inhibition of BChE. These results indicate that D. reflexa can have neuroprotective potential and can be studied in the management of neurodegenerative disorders like Alzheimer’s disease.

Ghallo BA et.al., (2022)

 

 

 

 

6

Tyrosinase inhibitory activity

Spectrophotometric tyrosinase inhibition assay using L-dopa as substrate

n-butanol and methanolic extractions

The tyrosinase inhibitory activity of D. reflexa extracts was determined spectrophotometrically using L-DOPA as substrate. Kojic acid was used as reference standard.

The n-butanol fraction showed the highest tyrosinase inhibition, pointing to the bioactive compounds which are capable of inhibiting melanin synthesis. This activity gives a glimpse of the possible uses of D. reflexa. This activity shows in the making use of D. reflexa in skin hyperpigmentation disorders and cosmetic formulations.

Ghallo BA et.al., (2022)

7

Anti-inflammatory activity

Carrageenan induced paw oedema model

 

 

 

 

 

 

Methanolic leaf extract

Acute oral toxicity study was performed as per OECD guideline 423 and the extract was found safe up to 2000 mg/kg and doses of 200 and 400 mg/kg were selected for pharmacological evaluation. The anti-inflammatory activity was determined by carrageenan induced paw oedema model.

The methanolic leaf extract of Dracaena reflexa (MEDR) showed significant anti-inflammatory effects. The results showed that MEDR inhibited the paw oedema in a dose-dependent manner. The 400 mg/kg dose of MEDR showed efficacy comparable to the standard drug dexamethasone

Kuchana, p.         et.al., (2021)

8

Anti-nociceptive activity

Acetic acid induced writhing, tail immersion and hot plate method in Wistar rats

 

 

Methanolic leaf extract

The analgesic activity was determined by acetic acid induced writhing, tail immersion and hot plate method in Wistar rats.

The methanolic leaf extract of Dracaena reflexa (MEDR) showed significant antinociceptive effects. The results showed that MEDR significantly reduced the pain responses in all the analgesic models. The 400 mg/kg dose of MEDR showed efficacy comparable to the standard drug diclofenac.

Kuchana, p.           et.al., (2021)

 

 

9

Anti-oxidant activity

In vitro antioxidant assays (DPPH radial scavenging assays, ABTS radical cation assay and ferric reducing antioxidant power

(FRAP) assay)

Methanolic extract

The antioxidant activity of Dracaena reflexa stem aqueous methanolic extract was determined by DPPH radical scavenging assay, ABTS radical cation assay and Ferric Reducing Antioxidant Power (FRAP) assay. The extract was evaluated for free radical scavenging and reducing capacity. Phenolic compounds, flavonoids and other bioactive phytoconstituents were identified by HPLC–ESI–MS/MS.

The extract showed moderate antioxidant potential by free radical scavenging and reducing capacity. In the DPPH assay, the extract gave an IC₅₀ value of 311.6 ± 10.10 µg/mL while Trolox showed higher activity with an IC₅₀ value of 24.42 ± 0.87 µg/mL. ABTS assay revealed antioxidant capacity of 326.63 µM Trolox equivalents (TE)/mg extract and FRAP assay revealed reducing power of 208.67 µM TE/mg extract. The antioxidant activity was found to be due to phenolic compounds, flavonoids and other bioactive phytoconstituents. The therapeutic potential of D. reflexa may be attributed to its antioxidant properties by alleviating oxidative stress and potentiating its pharmacological activities including wound healing.

Raslan MA et.al.,(2022)

 

 

 

 

 

 

10

Anti-oxidant activity

In vitro antioxidant assays (DPPH, ABTS, CUPRAC, and FRAP assays)

Methanolic extract and different solvent (n-hexane, chloroform and n-butanol)

The antioxidant potential of Dracaena reflexa extracts was determined based on free radical scavenging ability and reducing power. Methanolic extract and different solvent fractions (n-hexane, chloroform and n-butanol) were tested. The antioxidant activity was correlated with total phenolic and flavonoid content.

Among the tested fractions, the n-butanol fraction exhibited the highest antioxidant activity due to its higher total phenolic and flavonoid content. Phenolic and flavonoid compounds helped in neutralising reactive oxygen species and reducing oxidative stress, indicating the potential of D. reflexa as a natural source of antioxidant compounds.

Ghallo BA et.al.,(2022)

11

Anti-oxidant activity

Isolated frog heart model

Methanolic root extract

The antioxidant activity was examined in an isolated frog heart model. Hydrogen peroxide (H₂O₂) was used to induce oxidative stress and ascorbic acid was used as a standard antioxidant. The protective effect of the extract was evaluated by assessing cardiac parameters such as heart rate, force of contraction and cardiac output.

The methanolic root extract showed protective effects against H₂O₂-induced oxidative damage by delaying cardiac arrest and improving cardiac parameters such as heart rate, force of contraction and cardiac output compared to the control group. The antioxidant potential may be due to the presence of bioactive phytoconstituents that scavenge free radicals and reduce oxidative stress.

Narendra B et.al.,(2017)

 

12

Anti-oxidant activity

In vitro antioxidant assays: DPPH radical scavenging activity and ferric reducing power (FRAP) assay

Petroleum ether extract, Dichloromethane extract, methanol extract, water extract

Antioxidant activity of Dracaena reflexa stem extracts was determined by DPPH radical scavenging activity and Ferric Reducing Antioxidant Power (FRAP) assay. The stem was extracted using Soxhlet extraction with different solvents (petroleum ether, dichloromethane, methanol and water). Antioxidant activity was compared with standard antioxidants (BHT and ascorbic acid).

Of the extracts, the dichloromethane extract showed the highest antioxidant activity, highest phenolic content and strong ability to scavenge free radicals. The activity was attributed mainly to the presence of phenolic and flavonoid compounds responsible for antioxidant effects through neutralising free radicals and reducing oxidative stress.  The present study shows that Dracaena reflexa has major antioxidant potential in vitro. On the other hand, in vivo studies and isolation of the active compounds are needed to establish its therapeutic applications.

Shukla A

et.al.,(2014)

13

Anti-bacterial activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agar well diffusion method against selected gram positive and gram-negative bacteria

n-hexane extract

Agar well diffusion method was employed to assess the antibacterial activity of Dracaena reflexa against selected gram positive and gram-negative bacteria. The n-hexane fraction of the plant extract was tested against co-amoxiclav as standard antibacterial drug

The extract was concentration dependent antibacterial activity; it showed inhibition of bacterial growth. The highest antibacterial effect of the tested organisms was observed on Bacillus pumilus. The activity may be because of the presence of bioactive phytoconstituents like phenolic compounds, flavonoids and other secondary metabolites. The findings suggest that D. reflexa can be a source of natural antibacterial agents and further research should be performed for the development of antimicrobial drugs.

Ghallo BA et.al., (2022)

14

Anti-bacterial activity

Agar disc diffusion method against gram positive and gram-negative bacterial strains

Petroleum ether extract, Dichloromethane extract, methanolic extract

The antibacterial activity of the leaf extracts of Dracaena reflexa was determined against Gram-positive and Gram-negative bacterial strains by the agar disc diffusion method. Petroleum ether, dichloromethane and methanolic extracts showed inhibitory activity against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. Kanamycin was used as a standard for comparison of the antibacterial agent.

Of the extracts tested, methanolic extract showed highest antibacterial activity against Pseudomonas aeruginosa with maximum zone of inhibition 32 mm. The extracts activity might be because of bioactive phytoconstituents such as flavonoids, alkaloids, tannins, terpenoids and saponins which are responsible for inhibition of bacterial growth. The results indicate that D. reflexa could be a natural source of antibacterial agents

Km. preeti et.al.,(2021)

15

Anti-bacterial activity

Agar cup plate method against Gram positive and Gram-negative bacterial strains

Methanolic root extract and Aqueous leaf extract

Antibacterial activity of both the extract of methanolic root and aqueous leaf of Dracaena reflexa var. angustifolia was evaluated against selected Gram-positive and Gram-negative bacterial strains. Antibacterial efficacy was determined by agar cup plate method using streptomycin as standard drug. The tested organisms were Staphylococcus aureus, Lactobacillus, Proteus vulgaris and Enterobacter aerogenes.

The antibacterial activity of the leaf extract in water was relatively more than that of the root extract in methanol as indicated by bigger zones of inhibitions against the microorganisms tested. The antibacterial effect may be due to the presence of bioactive phytoconstituents like phenolic compounds, flavonoids and other secondary metabolites, which interferes with bacterial growth and survival.

Narendra B et.al.,(2017)

3. TRADITIONAL USES:

Dracaena reflexa has been employed in traditional Indian herbal medicine for different therapeutic uses. The leaves and stems are often used as a natural antiseptic and germicidal agent, especially to prevent infections and promote the healing of wounds. Traditional practices also describe its use as an expectorant for relief in cough and chest related problems. The plant is said to have antimicrobial properties and has been used traditionally in the treatment of conditions such as fever, diarrhoea, malaria and inflammatory disorders. The bioactive compounds present in D. reflexa are thot to be responsible for the traditional uses such as antioxidant, antibacterial, antifungal, and healing activities. Apart from its significance in medicine, D. reflexa is a popular ornamental plant because of its contribution in improving indoor air quality by removing some toxins in the environment.11

CONCLUSION

There are many pharmacological potentials of Dracaena reflexa which can be utilised for making natural medicines based on the research of today. The phytochemicals such as flavonoids and phenolic compounds are responsible for its antioxidant, antibacterial, anti-inflammatory, analgesic and other biological properties. It has been highlighted as a medicinal plant and its traditional uses have been scientifically proven thru experimental investigation. But most of the evidence we have today comes from early laboratory research. Further detailed studies are required for isolation of bioactive compounds, toxicity, molecular studies and clinical trials to confirm its efficacy and safety in humans. More research on the Dracaena reflexa plant can lead to the production of new plant-based medicines.

REFERENCES

  1. Mulani AS, Chavan SD, Patil SS, Misal MM and Chougule K: "Exploring the medicinal potential of Dracaena reflexa lam.: a comprehensive review of its therapeutic applications". Int J Pharm Sci & Res 2025; 16(10): 2700-06. doi: 10.13040/IJPSR.0975-8232.16(10).2700-06.
  2. Manimaran P, Saravanan SP, Sanjay MR, Siengchin S, Jawaid M, Khan A. Characterization of new cellulosic fiber: Dracaena reflexa as a reinforcement for polymer composite structures. Journal of Materials Research and Technology. 2019 Apr 1;8(2):1952-63. https://doi.org/10.1016/j.jmrt.2018.12.015
  3. Singh P, Darbari S, Kandari K, Goel G. PHARMACOGNOSTIC AND PHYSICAL EVALUATION OF LEAVES OF DRACAENA REFLEXA LAM. Advance and Innovative Research. 2025 Jun 7.
  4. Kuchana P, Sujatha E. Assessment of Anti-nociceptive and Anti-inflammatory Potentials of Dracaena Reflexa Leaves. International Journal of Health Sciences.;5(S2):571-81.
  5. Judicaël BD, Nadege OA, Lazard PM, Ella LN, Antoine AA. Evaluation of anticonvulsant and anxiolytic effects of aqueous extract of Dracaena reflexa leaves in rats. American Journal of BioScience. 2022 Dec;10(6):201-5.
  6. Raslan MA, Afifi AH. In vitro wound healing properties, antioxidant activities, HPLC–ESI–MS/MS profile and phytoconstituents of the stem aqueous methanolic extract of Dracaena reflexa Lam. Biomedical Chromatography. 2022 Jun;36(6):e5352.
  7. Ghalloo BA, Khan KU, Ahmad S, Aati HY, Al-Qahtani JH, Ali B, Mukhtar I, Hussain M, Shahzad MN, Ahmed I. Phytochemical profiling, in vitro biological activities, and in silico molecular docking studies of Dracaena reflexa. Molecules. 2022 Jan 28;27(3):913
  8. Shukla A, Vats S, Shukla RK. Proximate composition, nutritive value and evaluation of antioxidant potential of stem of Dracaena reflexa Lam. Int J Pharm Pharm Sci. 2014;6(11):360-4.
  9. Narender B, Naveena N, Pravalika P, kaleem S, Vamshi M, Mandhadi JR. Pharmacological evaluation of the root and leaf extract of dracaena reflexa var. angustifolia. Innov Pharm pharmacother 2017;5(3):141-146
  10. Preeti K, Kumar A, Joshi P. Proximate analysis and antibacterial activity of Dracaena reflexa leaves. Int J Res Anal Rev. 2021;8(4):376-386. https://ijrar.org/papers/IJRAR21D1286
  11. Mulani AS, Chavan SD, Patil SS, Misal MM and Chougule K: "Exploring the medicinal potential of Dracaena reflexa lam.: a comprehensive review of its therapeutic applications". Int J Pharm Sci & Res 2025; 16(10): 2700-06. doi: 10.13040/IJPSR.0975-8232.16(10).2700-06.

Reference

  1. Mulani AS, Chavan SD, Patil SS, Misal MM and Chougule K: "Exploring the medicinal potential of Dracaena reflexa lam.: a comprehensive review of its therapeutic applications". Int J Pharm Sci & Res 2025; 16(10): 2700-06. doi: 10.13040/IJPSR.0975-8232.16(10).2700-06.
  2. Manimaran P, Saravanan SP, Sanjay MR, Siengchin S, Jawaid M, Khan A. Characterization of new cellulosic fiber: Dracaena reflexa as a reinforcement for polymer composite structures. Journal of Materials Research and Technology. 2019 Apr 1;8(2):1952-63. https://doi.org/10.1016/j.jmrt.2018.12.015
  3. Singh P, Darbari S, Kandari K, Goel G. PHARMACOGNOSTIC AND PHYSICAL EVALUATION OF LEAVES OF DRACAENA REFLEXA LAM. Advance and Innovative Research. 2025 Jun 7.
  4. Kuchana P, Sujatha E. Assessment of Anti-nociceptive and Anti-inflammatory Potentials of Dracaena Reflexa Leaves. International Journal of Health Sciences.;5(S2):571-81.
  5. Judicaël BD, Nadege OA, Lazard PM, Ella LN, Antoine AA. Evaluation of anticonvulsant and anxiolytic effects of aqueous extract of Dracaena reflexa leaves in rats. American Journal of BioScience. 2022 Dec;10(6):201-5.
  6. Raslan MA, Afifi AH. In vitro wound healing properties, antioxidant activities, HPLC–ESI–MS/MS profile and phytoconstituents of the stem aqueous methanolic extract of Dracaena reflexa Lam. Biomedical Chromatography. 2022 Jun;36(6):e5352.
  7. Ghalloo BA, Khan KU, Ahmad S, Aati HY, Al-Qahtani JH, Ali B, Mukhtar I, Hussain M, Shahzad MN, Ahmed I. Phytochemical profiling, in vitro biological activities, and in silico molecular docking studies of Dracaena reflexa. Molecules. 2022 Jan 28;27(3):913
  8. Shukla A, Vats S, Shukla RK. Proximate composition, nutritive value and evaluation of antioxidant potential of stem of Dracaena reflexa Lam. Int J Pharm Pharm Sci. 2014;6(11):360-4.
  9. Narender B, Naveena N, Pravalika P, kaleem S, Vamshi M, Mandhadi JR. Pharmacological evaluation of the root and leaf extract of dracaena reflexa var. angustifolia. Innov Pharm pharmacother 2017;5(3):141-146
  10. Preeti K, Kumar A, Joshi P. Proximate analysis and antibacterial activity of Dracaena reflexa leaves. Int J Res Anal Rev. 2021;8(4):376-386. https://ijrar.org/papers/IJRAR21D1286
  11. Mulani AS, Chavan SD, Patil SS, Misal MM and Chougule K: "Exploring the medicinal potential of Dracaena reflexa lam.: a comprehensive review of its therapeutic applications". Int J Pharm Sci & Res 2025; 16(10): 2700-06. doi: 10.13040/IJPSR.0975-8232.16(10).2700-06.

Photo
Sudhansu Kumar Choudhary
Corresponding author

Department of Pharmacology, The Oxford College of Pharmacy, Bengaluru, India

Photo
Sravanthi A
Co-author

Department of Pharmacology, The Oxford College of Pharmacy, Bengaluru, India

Photo
Soniya Patel
Co-author

Department of Pharmacology, The Oxford College of Pharmacy, Bengaluru, India

Photo
Shabari
Co-author

Department of Pharmacology, The Oxford College of Pharmacy, Bengaluru, India

Photo
Shivakumara Masthara
Co-author

Department of Pharmacology, The Oxford College of Pharmacy, Bengaluru, India

Sravanthi A, Sudhansu Kumar Choudhary, Soniya Patel, Shabari, Shivakumara Masthara, A Comprehensive Review on the Pharmacological Activities and Therapeutic Potential of Dracaena reflexa, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 8, 5345-5356. https://doi.org/10.5281/zenodo.22219920

More related articles
Upgradation of the Indian Pharmacovigilance System...
Rashmi Chandra, Shoebul Haque, Tripthy Shetty, Anoop Kumar...
Emerging Pharmacology of Metabolic Dysfunction-Ass...
Ankita Shindalkar, Vasundhara Wadulkar, Vaishnavi Patil, Sadiya S...
Nanosponges in Drug Delivery: Preparation, Recent ...
Faizan Saiyed, Biplab Debnath, Dr. D. B. Meshram, Tejas Patel, Ya...
Understanding Hypersexuality: Diagnosis And Treatment Approaches ...
Dr. S. Yogakrishnan, Syed Athil Ismail S.K , Shree Madhu M, Sneha S., Sanjay Kishore S.S, S. Mohamed...
Related Articles
Drug Usage Pattern of Lower Respiratory Tract Infection in Paediatric at Tertiar...
Merlin Babu, Nandini G Shenoy, Mohammad Rafiq, J. S. Venkatesh...
Bilayer and Multilayer Tablet for Combination Therapy...
Sharvari Mhaske, Kiran Rayate, Namrata Godhari, Vaishnavi Devhad, Rahul Khaire...
Upgradation of the Indian Pharmacovigilance System: Developments, Achievements, ...
Rashmi Chandra, Shoebul Haque, Tripthy Shetty, Anoop Kumar...
More related articles
Upgradation of the Indian Pharmacovigilance System: Developments, Achievements, ...
Rashmi Chandra, Shoebul Haque, Tripthy Shetty, Anoop Kumar...
Emerging Pharmacology of Metabolic Dysfunction-Associated Steatotic Liver Diseas...
Ankita Shindalkar, Vasundhara Wadulkar, Vaishnavi Patil, Sadiya Shaikh, Dr. Prajakta Kelgaonkar...
Nanosponges in Drug Delivery: Preparation, Recent Advances, QbD Approaches, Appl...
Faizan Saiyed, Biplab Debnath, Dr. D. B. Meshram, Tejas Patel, Yagnesh Modi, Dhrumil Patel...
Upgradation of the Indian Pharmacovigilance System: Developments, Achievements, ...
Rashmi Chandra, Shoebul Haque, Tripthy Shetty, Anoop Kumar...
Emerging Pharmacology of Metabolic Dysfunction-Associated Steatotic Liver Diseas...
Ankita Shindalkar, Vasundhara Wadulkar, Vaishnavi Patil, Sadiya Shaikh, Dr. Prajakta Kelgaonkar...
Nanosponges in Drug Delivery: Preparation, Recent Advances, QbD Approaches, Appl...
Faizan Saiyed, Biplab Debnath, Dr. D. B. Meshram, Tejas Patel, Yagnesh Modi, Dhrumil Patel...